BTG Regulatory News (BTG)

12 November 2015

BTG plc - Directorship Notification under Listing Rule 9.6.14

Pursuant to the Financial Services Authority Listing Rule 9.6.14(2), BTG plc (the "Company") would like to announce that James O'Shea, who is a non-executive director of the Company, has been appointed as a non-executive director of Ocular Therapeutix™, Inc. (a US based public company whose shares are traded on the NASDAQ Stock Exchange) with effect from 5 November, 2015

- ends -

Contact for Queries:

Andy Burrows, Vice President, Corporate and Investor Relations

+44 (0)20 7575 1741